News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,013 Results
Type
Article (14938)
Company Profile (300)
Press Release (266769)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79917)
Career Advice (169)
Deals (13352)
Drug Delivery (39)
Drug Development (50737)
Employer Resources (31)
FDA (5845)
Job Trends (5175)
News (145231)
Policy (10100)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (927)
Accelerated approval (19)
Adcomms (14)
Allergies (82)
Alliances (21779)
ALS (124)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (241)
Approvals (6039)
Artificial intelligence (259)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4566)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (343)
Cancer (3127)
Cardiovascular disease (237)
Career advice (153)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43692)
Collaboration (1149)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1103)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4318)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1382)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31669)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51737)
Executive appointments (621)
FDA (7595)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (981)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (504)
Government (1157)
Grass and pollen (3)
Guidances (166)
Healthcare (6620)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1208)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (166)
Interviews (19)
IPO (7358)
IRA (12)
Job creations (871)
Job search strategy (135)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1403)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (375)
MASH (131)
Medical device (2680)
Medtech (2689)
Mergers & acquisitions (6617)
Metabolic disorders (725)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1951)
Neurotech (1)
NextGen: Class of 2026 (2041)
Non-profit (873)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (327)
Peanut (43)
People (26674)
Pharmaceutical (45)
Pharmacy benefit managers (7)
Phase 1 (15484)
Phase 2 (20296)
Phase 3 (12829)
Pipeline (3240)
Policy (91)
Postmarket research (856)
Preclinical (6538)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (647)
Real estate (1450)
Recruiting (12)
Regulatory (9908)
Reports (19)
Research institute (972)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2010)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (335)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (344)
Last 30 days (1205)
Last 365 days (17804)
2026 (1651)
2025 (18108)
2024 (20566)
2023 (22438)
2022 (26851)
2021 (27856)
2020 (23411)
2019 (16277)
2018 (11772)
2017 (13770)
2016 (11859)
2015 (14378)
2014 (10407)
2013 (7494)
2012 (7541)
2011 (7628)
2010 (7444)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18270)
Australia (3116)
California (7078)
Canada (1836)
China (772)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39202)
Florida (903)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (160)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (739)
Massachusetts (5581)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1648)
New Mexico (13)
New York (1761)
North Carolina (828)
North Dakota (6)
Northern California (3474)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1276)
Puerto Rico (9)
Rhode Island (25)
South America (216)
South Carolina (9)
Southern California (2808)
Tennessee (40)
Texas (904)
United States (23340)
Utah (97)
Virginia (138)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
282,013 Results for "nested therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cliniphai and Nested Knowledge Announce Partnership at ISPOR Europe 2025 to Accelerate Global Health Technology Assessment (HTA) Dossier Localization with AI
November 13, 2025
·
1 min read
Genetown
Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue
Nested Therapeutics today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND) application for NST-628 for the treatment of patients with advanced solid tumors harboring genetic alterations in the RAS-MAPK pathway.
March 28, 2024
·
3 min read
Genetown
Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting
Nested Therapeutics today announced that preclinical data from its lead program, NST-628, will be featured in an oral presentation in the “New Drugs on the Horizon” series at the American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California from April 5-10, 2024.
March 28, 2024
·
2 min read
Biotech Beach
Nested Therapeutics Announces Oral Presentation of Preclinical Data for NST-628, a Novel, Fully Brain-Penetrant, Pan-RAF/MEK Molecular Glue, at the 2024 AACR Annual Meeting
Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that preclinical data for the company’s lead program, NST-628, were featured in an oral presentation in the “New Drugs on the Horizon” series at the American Association for Cancer Research (AACR) Annual Meeting.
April 8, 2024
·
5 min read
Press Releases
Inductive Bio Announces Publication of Successful Drug Optimization Collaboration with Nested Therapeutics
July 29, 2024
·
2 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Pharm Country
West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
West Pharmaceutical Services, Inc. announced that it will unveil its new Daikyo Crystal Zenith® Nested Vials in Tub at the International Society for Cell and Gene Therapy Annual Meeting taking place in Vancouver, Canada from May 29- June 1.
May 29, 2024
·
2 min read
Genetown
Nested Therapeutics Launches With $125 Million Financing
Nested Therapeutics announced the completion of a $90 million Series A financing led by the Life Sciences Investing business within Goldman Sachs Asset Management, bringing the total financing to $125 million since Versant Ventures founded the company.
October 6, 2022
·
8 min read
Genetown
Nested Therapeutics to Present Preclinical Data for Novel, Potential Best-in-Class Inhibitor of the RAS/MAPK Pathway at 2023 AACR-NCI-EORTC Conference
Nested Therapeutics today announced it will present preclinical data from its lead candidate, NST-628, a mechanistically novel non-degrading molecular glue that targets multiple nodes in the RAS/MAPK pathway, at the upcoming 2023 AACR-NCI-EORTC International Conference taking place in Boston, Massachusetts from October 11 – 15, 2023.
October 4, 2023
·
2 min read
Genetown
Nested Therapeutics Presents First Preclinical Data for Lead Candidate, NST-628, a RAS/MAPK Pathway Inhibitor at 2023 AACR-NCI-EORTC Conference
Nested Therapeutics today presented the first preclinical data from its lead candidate, NST-628, a mechanistically novel non-degrading molecular glue that targets multiple nodes in the RAS/MAPK pathway, outlined in three poster presentations at the 2023 AACR-NCI-EORTC International Conference taking place in Boston, Massachusetts from October 11-15, 2023.
October 12, 2023
·
4 min read
1 of 28,202
Next
